|
|
||||||||
AJP - Endocrinology and Metabolism, Vol 269, Issue 6 E991-E995, Copyright © 1995 by American Physiological Society
ARTICLES |
E. Guillot, R. Morand, C. Bouloy, M. T. Eon and I. Angel
Department of Internal Medicine, Synthelabo Recherche, Rueil-Malmaison, France.
The effects of alpha 2-adrenoceptor blockade or activation on glucose, insulin, free fatty acids (FFA), and glycerol responses to a mixed meal were studied in the beagle dog. The alpha 2-adrenoceptor antagonist deriglidole (1 mg/kg po), administered 45 min before feeding, significantly reduced glycemia and increased insulin, FFA, and glycerol levels. Although the alpha 2-adrenoceptor agonist UK-14.304 (3 micrograms/kg sc), administered 15 min before feeding, had no effect per se, it completely blocked meal-induced insulin release, thus promoting a mild increase in glycemia, and prolonged the meal-induced FFA decrease. Deriglidole antagonized the reduction of insulin secretion and the hyperglycemia induced by UK-14.304. The meal-induced fall in FFA levels was still observed after deriglidole treatment and was markedly amplified when UK-14.304 was administered with deriglidole. These results suggest that, in the dog, insulin release and lipolysis are very sensitive to alpha 2-adrenoceptor stimulation. It is also suggested that the meal-evoked decrease in lipid mobilization results from an increase in alpha 2-adrenoceptor stimulation rather than from an increase in insulin secretion.
This article has been cited by other articles:
![]() |
A. Natali, A. Gastaldelli, A. Q. Galvan, A. M. Sironi, D. Ciociaro, G. Sanna, P. Rosenzweig, and E. Ferrannini Effects of acute alpha 2-blockade on insulin action and secretion in humans Am J Physiol Endocrinol Metab, January 1, 1998; 274(1): E57 - E64. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |